The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Chase Randal D since 2005.
This trader's CIK number is 1078784.
At the time of last reporting, Chase Randal D was the Director of Geovax Labs, Inc.. (stock ticker symbol GOVX).
Also see all insider trading activities at Geovax Labs, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2009 | BJCT | 0 | $0 | 0 | $0 | 19,000 | $0 |
| 2008 | BJCT | 0 | $0 | 0 | $0 | 31,000 | $0 |
| 2007 | BJCT | 10,000 | $13,600 | 0 | $0 | 16,750 | $0 |
| 2006 | BJCT | 15,000 | $20,190 | 0 | $0 | 4,750 | $0 |
| 2005 | BJCT | 5,000 | $6,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | GOVX | 20,000 | $23,100 | 0 | $0 | 0 | $0 |
| 2020 | GOVX | 16,613 | $83,065 | 0 | $0 | 0 | $0 |
| 2015 | GOVX | 40,000 | $6,990 | 0 | $0 | 0 | $0 |
1. Bioject Medical Technologies Inc (BJCT)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-06-05 | BJCT | Option Ex | 19,000 | .00 | 0 |
| 2008-12-05 | BJCT | Option Ex | 19,000 | .00 | 0 |
| 2008-06-14 | BJCT | Option Ex | 12,000 | .00 | 0 |
| 2007-12-14 | BJCT | Option Ex | 12,000 | .00 | 0 |
| 2007-06-14 | BJCT | Buy | 10,000 | 1.36 | 13,600 |
| 2007-05-24 | BJCT | Option Ex | 4,750 | .00 | 0 |
| 2006-11-27 | BJCT | Option Ex | 4,750 | .00 | 0 |
| 2006-06-07 | BJCT | Buy | 15,000 | 1.35 | 20,190 |
| 2005-06-10 | BJCT | Buy | 5,000 | 1.20 | 6,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-09-21 | GOVX | Buy | 10,000 | 1.10 | 11,000 |
| 2022-06-21 | GOVX | Buy | 10,000 | 1.21 | 12,100 |
| 2020-09-29 | GOVX | Buy | 16,613 | 5.00 | 83,065 |
| 2015-05-05 | GOVX | Buy | 10,000 | .19 | 1,890 |
| 2015-04-20 | GOVX | Buy | 30,000 | .17 | 5,100 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chase Randal D (Director of Geovax Labs, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.